India  

Adar Poonawalla

Indian businessman

Adar Poonawalla    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.

0
shares
ShareTweetSavePostSend
 
PM Modi attends strategy session ahead of elections in 5 states| Oneindia News [Video]

PM Modi attends strategy session ahead of elections in 5 states| Oneindia News

A BJP youth leader was arrested Friday evening in Bengal's Kolkata for allegedly carrying 100 gm of cocaine. Ahead of elections in five states, Prime Minister Narendra Modi is participating in a..

Credit: Oneindia     Duration: 02:19Published

Vaccine manufacturer: Global harmonization of regulation is lacking [Video]

Vaccine manufacturer: Global harmonization of regulation is lacking

The Serum Institute of India is the world’s biggest manufacturer of vaccines. CEO Adar Poonawalla blames a lack of standardized information for delays in vaccine distribution.

Credit: Bleacher Report AOL     Duration: 03:45Published
Fire has no impact on 'Covishield' vaccine production: Serum Institute of India [Video]

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine. "The extent of the damage is more than 1,000 crores...

Credit: ANI     Duration: 01:16Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine [Video]

Watch: SII CEO Poonawalla receives shot of Covishield vaccine

Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...

Credit: ANI     Duration: 01:08Published
Release of first consignment of Covishield brings cheer to SII employees [Video]

Release of first consignment of Covishield brings cheer to SII employees

Employees and CEO-owner of Serum Institute of India (SII) Adar Poonawalla applauded at their office in Pune, as the first consignment of Covishield was dispatched across India on January 12.

Credit: ANI     Duration: 01:10Published
Special price of Rs 200 for first 100 million doses only to GoI: Adar Poonawalla [Video]

Special price of Rs 200 for first 100 million doses only to GoI: Adar Poonawalla

The first batch of COVID-19 vaccine 'Covishield' dispatched by Serum Institute of India (SII) in Pune arrived in various states including Delhi, Chennai, Bengaluru, Bihar and Hyderabad. The COVID..

Credit: ANI     Duration: 01:20Published
India's vaccine supply is biggest: Serum Institute of India CEO [Video]

India's vaccine supply is biggest: Serum Institute of India CEO

Serum Institute of India, CEO Adar Poonawalla on supply of vaccines to other countries said that people are looking up to India because it has one of the biggest vaccines supply. Poonawalla said, "We..

Credit: ANI     Duration: 01:06Published
Planning is underway: Adar Poonawalla on rollout of vaccines for India, foreign countries [Video]

Planning is underway: Adar Poonawalla on rollout of vaccines for India, foreign countries

Serum Institute of India, CEO Adar Poonawalla on the roll out of vaccine assured that Health Ministry has made extensive logistic plans for the roll out. Poonawalla further informed that Serum..

Credit: ANI     Duration: 01:22Published

You Might Like


Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has..
IndiaTimes - Published

India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month'

The Serum Institute of India will ship the Oxford University/AstraZeneca Covid-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday. "As we await regulatory approvals..
IndiaTimes - Published

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch..
IndiaTimes - Published

COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said

The vaccine is being developed in partnership with American vaccine developer Novavax.
DNA - Published

Serum Institute applies to conduct local trial for Novavax vaccine: CEO

The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3%..
IndiaTimes - Published

SII to send 3m Covid shots to Saudi in a week: Poonawalla


IndiaTimes - Published

Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said its manufacturing plant at Manjari here suffered a loss of over Rs1,000 crore in Thursday’s fire that claimed five lives.
IndiaTimes - Published

Serum Institute fire: Vaccine supply won't be affected, says CEO Adar Poonawalla


IndiaTimes - Published

Serum Institute fire: Adar Poonawalla explains why he tweeted, 'no lives lost'

Adar Poonawalla has given an explanation on his tweet that he did after fire broke out at Serum Institute's facility in Pune on Thursday afternoon.
DNA - Published

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra's Pune on Thursday afternoon.
DNA - Published

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here

Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000.
DNA - Published

Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla

"We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare..
IndiaTimes - Published

Brazil dials India on Covid vaccine imports

India’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of..
IndiaTimes - Published

Private hospitals, companies may get vaccine by March: Serum CEO

SII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,..
IndiaTimes - Published

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit
DNA - Published

Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla


IndiaTimes - Published

SII CEO thanks PM Modi for support after seeking emergency authorisation of its Covid vaccine

After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the..
IndiaTimes - Published

COVID-19 'Virus Busters': Serum Insititute of India's Adar Poonawalla among six named 'Asians of The Year'

Poonawala joined the Serum Institute of India in 2001 and took over the day-to-day operations of the company as CEO in 2011.
DNA - Published

Formed task force in Maha to manage COVID vaccine distribution; in touch with Serum CEO: Thackeray to PM Modi

Maharashtra is in touch with Adar Poonawalla, CEO of Serum Institute of India, for coronavirus vaccine, CM Uddhav Thackeray told PM Modi.
DNA - Published

Covid vaccine should be available for public by April 2021: Serum Institute CEO

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by..
IndiaTimes - Published

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
DNA - Published

Vaccine may be ready for use as early as December: Adar Poonawalla


IndiaTimes - Published

I wish government's Covid vaccine strategy was 'Mann ki Baat': Rahul Gandhi

Gandhi's tweet came after Prime Minister Narendra Modi aired his monthly 'Mann ki baat' programme on the All India Radio (AIR). Along with his comment, Gandhi shared a news report regarding Serum..
IndiaTimes - Published

Applaud PM's vision on providing vaccines to global community: Serum's Adar Poonawalla


IndiaTimes - Published

Govt will need 80,000 crore for Covid vaccine, says Serum CEO

The government may need Rs 80,000 crore over the next one year for distribution of Covid-19 vaccine and immunization of the country’s population, Adar Poonawalla, CEO and promoter of the world’s..
IndiaTimes - Published

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks

On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DNA - Published

Covid-19 vaccine by October-November: Adar Poonawalla to Naveen Patnaik

Adar Poonawalla, during an interaction with Odisha chief minister Naveen Patnaik through a video conference, expressed optimism that the Covid-19 vaccine could be ready by October-November this year..
IndiaTimes - Published